A discussion with Michael Reardon, M.D. about the state of transcatheter aortic valve replacement (TAVR) as of late 2016 ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
November 9, 2016 — Patients who undergo minimally invasive heart valve replacement, known as transcatheter aortic valve ...
Brijeshwar Maini, M.D., and Brian Bethea, M.D., from Tenet Florida’s structural heart program, explain the importance of ...
Krishna Rocha-Singh, M.D., Prairie Vascular Institute, Springfield, Ill., explains advancements in device therapy for ...
Studies have shown transcatheter aortic valve replacement (TAVR) has an increased risk of stroke and cerebral damage due ...
November 7, 2016 — Edwards Lifesciences Corp. recently announced new data demonstrating dramatic and sustained ...
November 7, 2016 – Results from the U.S. real-world, post-FDA approval experience of the Watchman device found high ...
November 7, 2016 — Keystone Heart Ltd. announced that data presented at the Transcatheter Cardiovascular Therapeutics ...
November 7, 2016 – A multicenter randomized trial evaluating the role of embolic protection using the Sentinel device ...
November 4, 2016 — Here is the list of the top 20 most popular pieces of content on the Diagnostic and Interventional ...
November 2, 2016 — St. Jude Medical Inc. announced the long-term data from RESPECT, a landmark trial, during a First ...
November 2, 2016 — Medtronic plc recently announced new clinical data for the Harmony Transcatheter Pulmonary Valve (TPV ...
November 2, 2016 — St. Jude Medical Inc. announced this week the U.S. Food and Drug Administration (FDA) approval and ...
November 1, 2016 — Edwards Lifesciences Corp. announced new five-year hemodynamic data from the PARTNER Trial ...
October 31, 2016 — Medtronic plc presented new positive data from two large registries aimed at evaluating 30-day ...